Effects of indacaterol/glycopyrronium (QVA149) on lung hyperinflation and physical activity in patients with moderate to severe COPD: a randomised, placebo-controlled, crossover study (The MOVE Study)
Crossref DOI link: https://doi.org/10.1186/s12890-016-0256-7
Published Online: 2016-06-14
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Watz, Henrik
Mailänder, Claudia
Baier, Monika
Kirsten, Anne
License valid from 2016-06-14